Ritholtz Wealth Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$425K Buy
1,592
+51
+3% +$13.8K 0.01% 843
2025
Q4
$387K Sell
1,541
-661
-30% -$176K 0.01% 807
2025
Q3
$632K Sell
2,202
-136
-6% -$36.4K 0.01% 615
2025
Q2
$614K Buy
2,338
+620
+36% +$151K 0.01% 585
2025
Q1
$400K Buy
1,718
+493
+40% +$120K 0.01% 651
2024
Q4
$281K Buy
+1,225
New +$281K 0.01% 728
2022
Q4
Sell
-2,401
Closed -$423K 668
2022
Q3
$423K Sell
2,401
-208
-8% -$42.6K 0.02% 446
2022
Q2
$525K Buy
2,609
+154
+6% +$32.8K 0.03% 308
2022
Q1
$556K Buy
2,455
+410
+20% +$96.4K 0.04% 285
2021
Q4
$552K Buy
2,045
+738
+56% +$183K 0.03% 281
2021
Q3
$316K Buy
+1,307
New +$329K 0.02% 361

Other funds holding LH

Ritholtz Wealth Management's LH Position: Q1 2026 in Review

Ritholtz Wealth Management increased its Labcorp (LH) stake by 3.3% in Q1 2026, buying an estimated $13.8K and bringing the position to 1,592 shares worth $425K. The position accounts for 0.01% of the portfolio, ranked #843.

Ritholtz Wealth Management first reported a position in LH in Q3 2021 and has held it in 11 quarters since. The position peaked at $632K in Q3 2025. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Ritholtz Wealth Management held 1,592 shares of Labcorp worth $425K as of Q1 2026.
  • Ritholtz Wealth Management bought 51 Labcorp shares in Q1 2026, an estimated $13.8K.
  • Labcorp made up 0.01% of Ritholtz Wealth Management's portfolio in Q1 2026, its #843 holding.
  • Ritholtz Wealth Management first reported a position in Labcorp in Q3 2021 and has held it in 11 quarters since.
  • Ritholtz Wealth Management's Labcorp position peaked at $632K in Q3 2025.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Ritholtz Wealth Management's 13F filing for Q1 2026, filed 20 Apr 2026.